Yuyun Xiong

P.R. China
Zhenjiang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

GGT6 as a Prognostic Biomarker and Therapeutic Target in Melanoma Using an Information-theoretical Method.

GGT6 as a Prognostic Biomarker and Therapeutic Target in Melanoma Using an Information-theoretical Method.

Journal: Cancer genomics & proteomics

Published: April 15, 2026

Advances in Understanding Immune Dysregulation and Therapeutic Strategies Targeting Epidermal and Dermal Cells in Keloids.

Advances in Understanding Immune Dysregulation and Therapeutic Strategies Targeting Epidermal and Dermal Cells in Keloids.

Journal: Iranian journal of immunology : IJI

Published: December 10, 2025

Association between sleep patterns, circadian rhythms, and hair loss in young adults.

Association between sleep patterns, circadian rhythms, and hair loss in young adults.

Journal: Chronobiology international

Published: August 22, 2025

Insights into human melanocyte development and characteristics through pluripotent stem cells combined with single-cell sequencing.

Insights into human melanocyte development and characteristics through pluripotent stem cells combined with single-cell sequencing.

Journal: iScience

Published: July 27, 2024

Using Network Pharmacology and Transcriptome Sequencing to Investigate the Mechanism of Action of Luteolin and Quercetin in Treating Obesity.

Using Network Pharmacology and Transcriptome Sequencing to Investigate the Mechanism of Action of Luteolin and Quercetin in Treating Obesity.

Journal: Chemical biology & drug design

Published: July 19, 2024

Co‑expression of SLC20A1 and ALDH1A3 is associated with poor prognosis, and SLC20A1 is required for the survival of ALDH1‑positive pancreatic cancer stem cells.

Co‑expression of SLC20A1 and ALDH1A3 is associated with poor prognosis, and SLC20A1 is required for the survival of ALDH1‑positive pancreatic cancer stem cells.

Journal: Oncology letters

Published: July 23, 2023

High SLC20A1 Expression Indicates Poor Prognosis in Prostate Cancer.

High SLC20A1 Expression Indicates Poor Prognosis in Prostate Cancer.

Journal: Cancer diagnosis & prognosis

Published: April 07, 2023

High Expression of CD58 and ALDH1A3 Predicts a Poor Prognosis in Basal-like Breast Cancer.

High Expression of CD58 and ALDH1A3 Predicts a Poor Prognosis in Basal-like Breast Cancer.

Journal: Anticancer research

Published: August 07, 2022

High SLC20A1 Expression Is Associated With Poor Prognosis for Radiotherapy of Estrogen Receptor-positive Breast Cancer.

High SLC20A1 Expression Is Associated With Poor Prognosis for Radiotherapy of Estrogen Receptor-positive Breast Cancer.

Journal: Cancer diagnosis & prognosis

Published: May 09, 2022

High Expression of p62 and ALDH1A3 Is Associated With Poor Prognosis in Luminal B Breast Cancer.

High Expression of p62 and ALDH1A3 Is Associated With Poor Prognosis in Luminal B Breast Cancer.

Journal: Anticancer research

Published: May 09, 2022

High expression of SLC20A1 is less effective for endocrine therapy and predicts late recurrence in ER-positive breast cancer.

High expression of SLC20A1 is less effective for endocrine therapy and predicts late recurrence in ER-positive breast cancer.

Journal: PloS one

Published: February 17, 2022

GLO 1 and PKCλ Regulate ALDH1-positive Breast Cancer Stem Cell Survival.

GLO 1 and PKCλ Regulate ALDH1-positive Breast Cancer Stem Cell Survival.

Journal: Anticancer research

Published: September 11, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026